バイオジェン株式会社
MX ˙ BMV ˙ US09062X1037
SecurityMX:BIIB / Biogen Inc.
InstitutionLMR Partners LLP
Latest Disclosed Ownership116,131 shares
Latest Disclosed Value $ 21,290,296
LMR Partners LLP ownership in BIIB / Biogen Inc.

On May 15, 2026 - LMR Partners LLP filed a 13F-HR form disclosing ownership of 116,131 shares of Biogen Inc. (MX:BIIB) valued at $21,290,296 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 8,630 shares of Biogen Inc.. This represents a change in shares of 1,245.67% during the quarter.

LMR Partners LLP has a history of taking positions in derivatives of the underlying security (BIIB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 154,300 of underlying shares valued at $28,287,819 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BIIB / Biogen Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOGEN COM 09062X103 116,131 107,501 1,245.67 21,290 1,302.50 0.0376
2026-02-17 2025-12-31 13F BIOGEN COM 09062X103 8,630 8,630 1,519 0.0029
2025-08-14 2025-06-30 13F BIOGEN COM 09062X103 0 -15,802 -100.00 0 -100.00
2025-05-15 2025-03-31 13F BIOGEN COM 09062X103 15,802 1,302 8.98 2,162 -2.48 0.0202
2025-02-14 2024-12-31 13F BIOGEN COM 09062X103 14,500 6,379 78.55 2,217 40.85 0.0186
2024-11-07 2024-09-30 13F BIOGEN COM 09062X103 8,121 1,661 25.71 1,574 5.14 0.0125
2024-08-14 2024-06-30 13F BIOGEN COM 09062X103 6,460 6,460 1,498 0.0126
2024-02-14 2023-12-31 13F BIOGEN COM 09062X103 0 -15,294 -100.00 0 -100.00
2023-11-14 2023-09-30 13F BIOGEN COM 09062X103 15,294 -160,027 -91.28 3,931 -92.13 0.0442
2023-08-14 2023-06-30 13F BIOGEN COM 09062X103 175,321 139,878 394.66 49,940 406.80 0.5543
2023-05-15 2023-03-31 13F BIOGEN COM 09062X103 35,443 35,443 9,854 0.1527
2022-05-16 2022-03-31 13F BIOGEN COM 09062X103 0 -23,381 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BIOGEN COM 09062X103 23,381 3,185 15.77 5,610 -1.84 0.0572
2021-11-15 2021-09-30 13F BIOGEN COM 09062X103 20,196 -2,610 -11.44 5,715 -27.63 0.0644
2021-08-16 2021-06-30 13F BIOGEN COM 09062X103 22,806 9,715 74.21 7,897 115.65 0.1193
2021-05-17 2021-03-31 13F BIOGEN COM 09062X103 13,091 -54,630 -80.67 3,662 -77.92 0.0912
2021-02-16 2020-12-31 13F BIOGEN COM 09062X103 67,721 67,721 16,582 0.2577
2020-08-14 2020-03-31 13F/A-1 BIOGEN COM 09062X103 0 -52,401 -100.00 0 -100.00
2020-02-14 2019-12-31 13F BIOGEN COM 09062X103 52,401 52,401 15,549 0.0255
2018-08-03 2018-06-30 13F BIOGEN COM 09062X103 0 -3,991 -100.00 0 -100.00
2018-05-04 2018-03-31 13F BIOGEN COM 09062X103 3,991 0 0.00 1,271 0.00 0.1306
2018-01-30 2017-12-31 13F BIOGEN COM 09062X103 3,991 3,991 1,271 0.1306
2017-11-09 2017-09-30 13F BIOGEN COM 09062X103 0 -6,099 -100.00 0 -100.00
2017-08-03 2017-06-30 13F BIOGEN COM 09062X103 6,099 -2,188 -26.40 1,656 -26.92 0.1039
2017-05-11 2017-03-31 13F BIOGEN COM 09062X103 8,287 4,871 142.59 2,266 133.85 0.2177
2017-02-07 2016-12-31 13F BIOGEN COM 09062X103 3,416 3,416 0.00 969 0.1488
2015-11-05 2015-09-30 13F BIOGEN COM 09062X103 0 -5,819 -100.00 0 -100.00
2015-08-10 2015-06-30 13F BIOGEN COM 09062X103 5,819 4,317 287.42 2,351 270.82 0.2873
2015-04-20 2015-03-31 13F BIOGEN COM 09062X103 1,502 -86 -5.42 634 17.63 0.0877
2015-01-20 2014-12-31 13F BIOGEN IDEC COM 09062X103 1,588 1,588 0.00 539 0.0704
2014-10-20 2014-09-30 13F BIOGEN IDEC COM 09062X103 0 -10,195 -100.00 0 -100.00
2014-07-10 2014-06-30 13F BIOGEN IDEC COM 09062X103 10,195 10,195 3,215 0.2674
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F BIOGEN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOGEN COM Call 92,500 270.00 23,773 233.84 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOGEN COM Call 25,000 7,121 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOGEN CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOGEN CALL Call 685,300 182,975 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOGEN COM Put 154,300 28,288 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOGEN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOGEN COM Put 72,800 -68.18 18,710 -71.29 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOGEN COM Put 228,800 65,174 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.